These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt, with results 2004-000602-44 Ensayo clínico en fase I-II de vinorelbina oral (Navelbine) en combinación con capecitabina en tratamiento de primera línea en pacientes con cáncer de mama avanzado 2009-10-14 not-yet-due
Reported results 2004-000665-35 Phase II study of oral vinorelbine in combination with capecitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes Estudio en fase II de vinorelbina oral en... 2007-12-19 due-trials
Reported results 2004-000748-26 Phase II trial of oral vinorelbine in combination with capecitabine and trastuzumab as first line therapy in women with previously untreated HER2 positive metastatic breast cancer. 2019-05-21 due-trials
Reported results 2004-000753-30 Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women with previously untreated HER2 negative metastatic breast cancer. 2007-11-03 due-trials
Reported results 2004-000962-11 Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma 2007-12-31 due-trials
Reported results 2004-000963-81 A Randomised Phase II study of Oral Vinorelbine or I.V. Vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines 2006-10-31 due-trials
Reported results 2004-001241-14 Efficacy of the topic RV3131A-HC3221 IN THE PREVENTION OF POLYMORPHIC LIGHT ERUPTION 2006-03-14 due-trials
Reported results 2004-001904-10 Prospective randomised clinical phase III trial of (alternating IV and oral) vinorelbine plus cisplatin versus docetaxel plus cisplatin in first line chemotherapy of locally advanced or metastatic non... 2006-05-31 due-trials
Completed, but no date 2004-002926-23 Evaluation of the impact of the moisturizing milk RV2478B on the use of corticoids and on quality of life, in a population of children with atopic dermatitis. bad-data
Reported results 2004-004249-16 THE EFFECT OF MILNACIPRAN 100MG BID ON SENSITIVITY TO STIMULUS-EVOKED PAIN IN PATIENTS WITH FIBROMYALGIA: A FMRI NEUROIMAGING STUDY 2007-04-26 due-trials
Completed, but no date 2004-004811-53 Ex-vivo study regarding the effects of Serenoa r. on the expression of VEGF vascular endothelial growth factor and microvessel density in patients with benign prostatic hypertrophy bad-data
Reported results 2004-004825-87 Efficacy and safety of 0,1%, 0,5% and 1% TAZAROTENE nail lacquer formulation versus vehicle in nail psoriasis. International, multicenter, double-blind, randomized study of four parallel groups. 2006-05-08 due-trials
Reported results 2004-004891-36 CROSS-OVER COMPARISON OF TESTOSTERONE SERUM LEVELS IN HYPOGONADAL MEN TREATED WITH L0074 TESTOSTERONE PATCH 60CM2 (2 patches/48H) AND ORAL TESTOSTERONE UNDECANOATE -PANTESTONE® 40mg- (2 caps, bid) 2005-09-19 due-trials
Reported results Terminated 2004-005135-26 ORAL VINORELBINE AND CISPLATIN WITH CONCOMITANT RADIOTHERAPY FOLLOWED BY EITHER CONSOLIDATION THERAPY WITH ORAL VINORELBINE AND CISPLATIN PLUS BEST SUPPORTIVE CARE OR BEST SUPPORTIVE CARE ALONE IN STA... 2012-05-09 due-trials
Reported results 2004-005205-30 Randomised phase II study of the combination of oral vinorelbine with capecitabine versus a sequential regimen of oral vinorelbine and capecitabine versus the combination of docetaxel and capecitabine... 2010-12-09 due-trials
Reported results 2005-000438-19 Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxel as first line chem... 2013-04-18 due-trials
Reported results 2005-000508-15 Efficacy and safety assessment of 6 months (24 weeks) treatment with Structum® 500 mg capsule bid in hip osteoarthritis: multicenter randomised double blind parallel group and placebo controlled study... 2006-11-07 due-trials
Reported results 2005-000869-20 Post-operative care by chlorhexidine mouthwash after periodontal surgery. Randomised, parallel groups; blind study, DC071BB versus placebo, in patients presenting with periodontal surgery with suture. 2006-06-03 due-trials
Reported results 2005-002803-18 RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND EFFICACY STUDY OF THE EMOLLIENT V0034CR IN ADDITION TO A MODERATELY POTENT CORTICOSTEROID IN THE ACUTE PHASE OF TREATMENT OF ATOPIC DERMATITIS IN INFANTS. 2006-06-02 due-trials
Reported results 2005-003137-40 A EUROPEAN PHASE III, MULTICENTRE, DOUBLE-BLIND,RANDOMISED,PLACEBO-CONTROLLED, MONOTHERAPY STUDY OF MILNACIPRAN FOR THE TREATMENT OF THE FIBROMYALGIA SYNDROME. 2007-09-04 due-trials
Reported results 2005-003396-21 LONG-TERM MANAGEMENT OF ATOPIC DERMATITIS WITH THE EMOLLIENT V0034 CR. A RANDOMISED, PLACEBO-CONTROLLED, PARALLEL-GROUPS, DOUBLE-BLIND STUDY IN INFANTS AND CHILDREN 2006-11-07 due-trials
Reported results 2005-005139-84 Evaluation Of The Rate Of Pathological Complete Response (pCR) For Neoadjuvant Chemoradiotherapy (CT-RT) And For Chemotherapy (CT) Alone in Locally Advanced Non Small Cell Lung Cancer (LA-NSCLC): A R... 2007-12-05 due-trials
Reported results 2005-005975-13 Randomised, double-blind, placebo-controlled dose-effect study of V0114 (2.5, 5, 7.5 and 10 mg) versus mequitazine 10 mg and placebo in the treatment of seasonal allergic rhinitis. 2006-08-14 due-trials
Reported results 2006-001139-23 Ensayo en fase III de vinflunina más gemcitabina frente a paclitaxel más gemcitabina en pacientes con cáncer de mama irresecable, localmente recurrente o metastásico, tras quimioterapia adyuvante pre... 2011-06-30 due-trials
Reported results 2006-001230-41 A EUROPEAN PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, MONOTHERAPY, 12-MONTH STUDY OF MILNACIPRAN FOR THE TREATMENT OF THE FIBROMYALGIA SYNDROME 2008-10-10 due-trials
Reported results 2006-002404-34 A DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, PLACEBO-CONTROLLED 10-WEEK STUDY ASSESSING THE EFFICACY AND SAFETY OF F2695 SR FLEXIBLE DOSE (75,100 MG /DAY) IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRES... 2007-10-22 due-trials
Reported results 2006-003369-14 Efficacy and tolerance of the emollient cream V0034 CR in the symptomatic treatment of ichthyosis in children. International, multicentric, randomised, controlled, double blind study, in parallel grou... 2007-11-01 due-trials
Reported results 2006-003378-90 TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age 2009-07-08 due-trials
Reported results 2006-003658-47 Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder. 2018-04-15 due-trials
Ongoing 2006-005672-41 Etude de l’efficacite de la dihydroergotamine par voie orale dans l’hypotension orthostatique de patients dysautonomiques not-yet-due
Ongoing 2006-006165-17 EFFICACY OF AN EARLY ADMINISTRATION OF L0013CP 10 MG/DAY VERSUS PLACEBO DURING 4 WEEKS IN THE TREATMENT OF INFECTIOUS DISEASES INDUCED ARTHRITIS PAINFUL SYMPTOMS. A MULTICENTER, RANDOMISED, DOUBLE BLI... not-yet-due
Reported results 2006-006354-98 “Transdermal testosterone supplementation in elderly hypogonadal men with sarcopenia: effects on muscle function, physical performance, body composition and quality of life.” A randomized, double-blin... 2008-05-15 due-trials
Reported results 2006-006569-18 EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS 2007-11-12 due-trials
Reported results 2006-006947-30 EFFICACY STUDY OF THE ANTIHISTAMINE V0114 CP 2.5MG TABLET IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY 2007-07-25 due-trials
Reported results 2006-007029-29 NON-INFERIORITY STUDY OF A METRONIDAZOLE 0.75% CREAM VERSUS REFERENCE THERAPY IN THE LOCAL TREATMENT OF PAPULOPUSTULAR ROSACEA. 2008-05-13 due-trials
Ongoing 2007-000504-32 Analyse du profil sensoriel du sirop antihistaminique Primalan®, versus un sirop antihistaminique de reference : Aerius® not-yet-due
Reported results 2007-000562-21 Effects of TANGANIL (three 500 mg tablets twice daily) on postural disturbances in the elderly. 2008-10-07 due-trials
Reported results 2007-000652-14 Etude en double aveugle versus placebo de l’efficacité et de la tolérance de Cirkan® sur la symptomatologie fonctionnelle veineuse éprouvée (C0s à C3s) par les patientes obèses 2007-12-13 due-trials
Completed, but no date, and reported results Terminated 2007-001058-16 A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION bad-data
Reported results 2007-001844-34 NON INFERIORITY STUDY OF A MALATHION 0.5% LOTION VERSUS REFERENCE THERAPY IN THE TREATMENT OF HEAD LICE: MULTICENTRE, RANDOMISED, INVESTIGATOR MASKED, PARALLEL GROUP. 2009-11-02 due-trials
Reported results 2007-001975-12 Evaluación del efecto de 6 meses de tratamiento con V0191 sobre la evolución de los síntomas en pacientes con un déficit cognitivo leve. Estudio multicéntrico, de asignación aleatoria, doble ciego, en... 2010-01-07 due-trials
Reported results 2007-002195-34 Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson’s disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups. 2010-07-02 due-trials
Reported results 2007-003230-42 STUDY OF THE ANALGESIC EFFECTS OF REPEATED DOSES OF F13640 IN SPINAL CORD INJURY PATIENTS WITH MODERATE TO SEVERE CENTRAL NEUROPATHIC PAIN A multinational, multicenter, randomized, double blind, para... 2009-05-18 due-trials
Reported results 2007-003249-34 Proof of Concept study of the efficacy and tolerability of a 4-week treatment with F13640 in patients in whom the adaptation of opioid therapy of cancer pain has failed. A prospective, multinational, ... 2009-05-18 due-trials
Reported results 2007-003572-19 EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE C... 2009-08-27 due-trials
Reported results 2007-003905-28 Etude randomisée, en groupes parallèles, en double insu, de l’efficacité de la méquitazine sur la symptomatologie et l’obstruction nasale chez des patients présentant une rhinite allergique perannuell... 2009-02-24 due-trials
Ongoing 2007-003987-23 Estudio en fase II de vinorelbina oral como tratamiento neoadyuvante en pacientes de más de 60 años con cáncer de mama localmente avanzado not-yet-due
Reported results 2007-004139-49 Efficacy and tolerability of 12-weeks oral treatment with V0355CP3A versus Ferrograd, in iron deficiency anaemia. Multicenter, randomised, open-label trial. 2009-03-31 due-trials
Reported results 2007-005054-23 A DOUBLE-BLIND PLACEBO CONTROLLED STUDY OF 1g, 2g, AND 4 g V0251 EFFICACY AND TOLERANCE IN VESTIBULAR NEURITIS 2010-04-19 due-trials
Ongoing 2007-005312-62 Etude chez le sujet volontaire sain de l’effet de carbolevure versus placebo sur la fermentation intestinale induite par l’ingestion de lactulose. not-yet-due
Reported results 2007-005921-31 Evaluation du pouvoir bactériostatique de la préparation V0079CR CETAVLON sur la flore cutanée au niveau des mains. Etude preuve de concept. 2008-10-06 due-trials
Reported results 2007-006029-29 Etude de l'efficacité de CIRKALM crème versus placebo dans le traitement des douleurs anales 2009-12-10 due-trials
Reported results 2007-006393-29 A 4-week double-blind placebo-controlled pilot study, evaluating niacin-induced flushing and lipid parameter effects of V0002 CA 1g 3 capsules/day associated with Niaspan® (from 375 mg to 1000 mg) in ... 2008-09-02 due-trials
Reported results 2007-006458-24 Analysis of the sensory profile of two new transdermal patches (V0116TD07AF019 and V0116TD07AF020) 21 mg/24h versus a reference transdermal patch (NICOTINELL TTS) 21 mg/24h. 2008-02-07 due-trials
Reported results 2007-007088-25 Efficacy and tolerance of V0071 GM 01A in inflammatory seborrhoeic dermatitis of the scalp. 2009-01-23 due-trials
Reported results 2007-007315-93 Human skin blanching essay comparing a new shampoo containing betamethasone dipropionate at 0.025% and 0.050% to three reference marketed formulations in healthy subjects 2008-07-11 due-trials
Ongoing 2007-007670-38 "Evaluation of erectyle disfonction in patients suffering from testosterone deficiency, before and after tretament by Testopatch" not-yet-due
Reported results 2008-000133-22 EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CO... 2008-08-30 due-trials
Completed, but no date, and reported results 2008-000487-17 Clinical trial of the efficacy and tolerability of an immunostimulant drug, composed by ribosomal fractions, in socialized paediatric patients in order to prevent recurrent respiratory infections. A r... bad-data
Reported results 2008-000871-19 Comparative study of efficacy and safety of Structum® and Chondrosulf® in patients with symptomatic osteoarthritis of the knee.A Multicenter, Randomized, Double-Blind, Double Placebo-Controlled, Paral... 2009-06-17 due-trials
Reported results 2008-000990-39 Reduction of the gingival inflammation by V0109 DI. Randomised, parallel groups, double blind study, V0109 DI versus placebo, in patients presenting gingivitis. 2009-12-12 due-trials
Completed, but no date, and reported results 2008-001860-36 EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTR... bad-data
Reported results 2008-002280-14 Comparative study of the effect of 4-week treatment with ossein-hydroxyapatite compound versus calcium carbonate on bone biomarkers in young women with low calcium intake. Prospective, monocenter, ran... 2009-01-13 due-trials
Ongoing 2008-002562-60 Phase III, multicentre, double-blind, randomised, placebo-controlled, study to assess the efficacy of V0337 SO 01A suspension 10ml 4 times a day during 7 days on 2 parallel groups of patients sufferin... not-yet-due
Ongoing 2008-003196-48 A phase II - III double-blind study of oral vinflunine plus best supportive care versus placebo plus best supportive care in patients with malignant pleural mesothelioma previously treated with system... not-yet-due
Reported results 2008-003485-25 Impact of the V0034CR 01B emollient on atopic dermatitis symptoms in children. A randomised, placebo-controlled, parallel-groups, double-blind study 2009-05-23 due-trials
Reported results 2008-004171-21 A phase III trial of vinflunine + capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with or resistant to an anthracycline and who are taxane resistant 2015-02-18 due-trials
Reported results 2008-007173-20 Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects. 2009-04-16 due-trials
Reported results 2008-008353-35 EFFICACY STUDY OF A CICLOPIROXOLAMINE 1% FOAM (DC115 GM 02A) VERSUS CICLOPIROXOLAMINE 1.5% SHAMPOO (SEBIPROX®) IN THE TREATMENT OF MODERATE SEBORRHEIC DERMATITIS OF THE SCALP 2009-12-14 due-trials
Reported results 2008-008734-36 EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTR... 2009-05-19 due-trials
Reported results 2009-011118-47 A phase III trial of IV vinflunine versus an alkylating agent in patients with metastatic breast cancer previously treated with or resistant to an anthracycline, a taxane, an antimetabolite and a vinc... 2014-02-28 due-trials
Reported results 2009-011125-14 A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution c... 2011-08-29 due-trials
Reported results 2009-011819-20 Effects of OMACOR in patients with a cardiac sodium channel gene SCN5A mutation, one variant of the congenital long-QT syndrome. A proof of concept study. 2010-05-25 due-trials
Reported results 2009-012001-19 Ensayo prospectivo, randomizado de fase II de vinorelbina oral y cisplatino o pemetrexed y cisplatino como primera línea de tratamiento en pacientes con Cáncer de Pulmón de Células No Pequeñas Metastá... 2012-11-09 due-trials
Reported results 2009-012123-28 A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy 2010-12-08 due-trials
Reported results 2009-013262-84 A randomised, controlled, multidose, multicentre, adaptive phase II/III study in infants with proliferating infantile hemangiomas requiring systemic therapy to compare four regimens of propranolol (1 ... 2013-11-05 due-trials
Reported results 2009-014049-10 Exploratory study of besipirdine efficacy and safety in male patients with persistent stress urinary incontinence after radical prostatectomy 2010-07-12 due-trials
Reported results 2009-014497-18 Estudio en fase II que evalúa vinorelbina oral como agente único en pacientes con cáncer de mama con receptores hormonales positivos y metástasis óseas y que han recibido tratamiento hormonal previo. ... 2015-06-30 due-trials
Reported results 2009-014516-35 EFFICACY AND TOLERABILITY OF CHONDROITIN SULPHATE 1000MG, TWICE DAILY IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS 2011-07-04 due-trials
Reported results 2009-014681-25 Pharmacodynamic and clinical assessment of DC 982 GE (2,4 or 6 capsules per day) in patients with chronic venous disorders : randomised, placebo-controlled, dose effect, double blind, parallel group ... 2010-11-09 due-trials
Reported results 2009-016601-42 A phase II multicentric study in adults with acute myelogenous leukaemia (AML) in first complete remission (CR1) using IV BuCy2 in a once daily Bu regimen targeting a narrow therapeutic window prior t... 2014-06-19 due-trials
Exempt, with results 2009-018102-22 A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy. 2011-06-07 not-yet-due
Reported results 2010-020620-22 Estudio en fase II aleatorizado para evaluar la combinación de vinflunina con gemcitabina y vinflunina con carboplatino en pacientes no elegibles para cisplatino con cáncer avanzado o metastásico de c... 2013-02-21 due-trials
Reported results 2010-020973-18 “Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing”. A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial. 2012-06-20 due-trials
Reported results 2010-023099-13 Eficacia y tolerancia de la suspensión oral V0251 en neuritis vestibular. Estudio aleatorizado, doble ciego y controlado con placebo. 2012-04-30 due-trials
Reported results 2010-023488-16 A multicentre, open-label study of propranolol in infants with proliferating infantile hemangioma requiring systemic therapy 2013-12-12 due-trials
Completed, but no date, and reported results Terminated 2010-024271-10 Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder bad-data
Reported results 2011-000272-34 Phase II study assessing the maintenance treatment with Vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the ur... 2015-03-17 due-trials
Reported results 2011-003144-50 A randomised, double blind, controlled, multicentre study in infants with infantile hemangioma to compare propranolol gel to placebo 2013-05-09 due-trials
Reported results 2011-003295-37 Efficacy of the V0034CR01B emollient on xerosis in children with atopic dermatitis. Randomised, vehicle-controlled, parallel-groups, double-blind study with an open label extension 2012-05-24 due-trials
Reported results 2011-003412-23 EFFECT OF V0251 IN ACUTE VERTIGO. A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED STUDY. 2013-04-15 due-trials
Reported results 2011-005081-38 Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated wit... 2018-11-23 due-trials
Reported results 2011-005307-33 Exploratory study of L.S.E.S.r. (PERMIXON 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH; a multinational, multicent... 2013-10-08 due-trials
Reported results 2011-005848-10 Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg, 35mg) after single administration in acute sore throat pain 2012-11-02 due-trials
Reported results 2012-001592-37 Effect of 3-month treatment with F2695 (75mg OD) on improving functional recovery of patients with ischemic stroke. A Multicenter, Randomised, Double-blind, Parallel-group, Placebo-Controlled Study ... 2015-02-11 due-trials
Reported results 2012-003361-18 Phase II trial of oral vinorelbine in Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) positive mutation after a failure to treat... 2016-01-15 due-trials
Reported results 2012-003487-48 Efficacy and safety international, multicentric, randomised,double- blind,placebo controlled study of F373280 for maintenance of sinus rhythm after electrical cardioversion in patients with persistent... 2017-04-03 due-trials
Reported results 2012-003530-16 Randomised phase II study evaluating, as first-line chemotherapy, weekly oral vinorelbine as a single-agent versus weekly paclitaxel as a single-agent in estrogen receptor positive, HER2 negative pati... 2018-09-05 due-trials
Reported results 2012-003531-40 Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcit... 2017-05-19 due-trials
Reported results 2012-004423-20 STUDY OF EFFICACY AND SAFETY OF V0498 VERSUS PLACEBO IN ACUTE SORE THROAT PAIN 2013-06-25 due-trials
Reported results 2012-004621-24 Emollients in the management of atopic dermatitis in children: prevention of flares. 2014-02-12 due-trials
Exempt, with results 2012-005241-20 Phase I-II study of F14512 in combination with cytarabine in patients 60 years old and older with acute myeloid leukemia. 2017-03-03 not-yet-due
Reported results 2013-001753-26 Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne. Evaluation clinique et biophysique des modifications cutanées s... 2014-02-20 due-trials
Reported results 2013-001760-31 Clinical efficacy and safety of J022X ST in the prevention of Recurrent Upper-Respiratory Tract Infections (RURTI) in children with a high risk of recurrence 2016-10-17 due-trials
Reported results 2013-002517-35 Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma 2014-04-22 due-trials
Exempt Terminated 2013-003009-24 PHASE I-II STUDY OF F17752 IN PATIENTS WITH ADVANCED SOLID TUMOURS 2013-10-13 not-yet-due
Reported results 2013-005451-32 Effects of F17464 in acute exacerbation of schizophrenia. 2015-12-22 due-trials
Reported results 2014-000222-38 PERMIXON® 160 mg hard capsule versus placebo in the treatment of symptomatic lower urinary tract symptoms due to benign prostatic hyperplasia. PERMIXON® 160 mg cápsulas duras frente a placebo en ... 2016-06-27 due-trials
Reported results 2014-002194-10 An intra-individual randomized controlled study to evaluate the efficacy and tolerance of the product RV4421A BS0042 in association with a moderately potent topical corticosteroid in adults with Atopi... 2015-07-09 due-trials
Reported results 2014-003859-61 Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy 2019-11-04 due-trials
Reported results 2014-003860-19 Randomised Phase II Study comparing, as first-line chemotherapy, single-agent Oral Vinorelbine administered with two different schedules in patients with Advanced Breast Cancer. 2020-09-28 due-trials
Reported results 2014-004682-24 Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction. Prospective, multicenter, randomised, double-blind, p... 2016-02-17 due-trials
Reported results 2014-005396-82 Randomized phase III study comparing vinflunine-gemcitabine and gemcitabine-carboplatin combinations in patients ineligible to cisplatin with advanced or metastatic urothelial carcinoma. 2017-01-08 due-trials
Reported results 2014-005555-80 Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study Eficacia y seguridad de la solución Hemangiol en el tratamiento del he... 2017-02-21 due-trials
Reported results 2014-005573-36 Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men 2016-04-28 due-trials
Reported results 2015-000995-88 Study of efficacy and safety of V0305 solution in children suffering from Iron Deficiency Anaemia (IDA). Phase 3, multicentre, single arm open-label study 2018-07-30 due-trials
Exempt, with results 2017-001842-82 Phase I/II open label dose escalation and dose expansion study of intravenous infusion of W0101, an antibody-drug conjugate, in patients with advanced or metastatic solid tumors International, multic... 2022-07-05 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2018-000271-32 Phase II, open-label, single arm, multicenter study of encorafenib, binimetinib plus cetuximab in subjects with previously untreated BRAF V600E -mutant Metastatic Colorectal Cancer 2023-04-27 bad-data
Not reported 2020-000851-11 Frequency and Intensity of local reactions in patients treated with 4% 5-FU vs 4% 5-FU associated with an emollient cream: a randomised, controlled clinical trial Fréquence et Intensité des réactio... 2022-01-31 due-trials
Completed, but no date 2021-000743-41 Adjuvant encorafenib & binimetinib vs. placebo in resected stage II BRAF V600E/K mutated melanoma: a randomized triple-blind Phase III Study in collaboration with the EORTC Melanoma Group. Encorafe... bad-data
Other 2021-002532-23 A prospective, open-label, genotype-match controlled, multicenter clinical trial to investigate the efficacy and safety of intra-amniotic ER004 as a prenatal treatment for male subjects with X-linked ... not-yet-due
Ongoing 2021-004310-19 Adjuvant encorafenib & binimetinib vs. placebo in fully resected stage IIB/C BRAF V600E/K mutated melanoma: a randomized triple-blind phase III study in collaboration with the EORTC Melanoma Group not-yet-due